Tranexamic acid in patients with intracerebral haemorrhage (STOP-AUST): a multicentre, randomised, placebo-controlled, phase 2 trial
The Lancet Neurology
Fecha de publicación: 28 de octubre de 202
DOI: https://doi.org/10.1016/S1474-4422(20)30369-0
Autores: Atte Meretoja, MD , Nawaf Yassi, PhD, Teddy Y Wu, PhD, Prof Leonid Churilov, PhD, Gerli Sibolt, PhD, Prof Jiann-Shing Jeng, PhD, et al.
Background: Despite intracerebral haemorrhage causing 5% of deaths worldwide, few evidence-based therapeutic strategies other than stroke unit care exist. Tranexamic acid decreases haemorrhage in conditions such as acute trauma and menorrhoea. We aimed to assess whether tranexamic acid reduces intracerebral haemorrhage growth in patients with acute intracerebral haemorrhage.
